James Radosevich

Person

Rockford, IL, US

People

Patents Grantslast 30 patents

Information Patent Grant
Gene encoding labyrinthin, a marker for cancer
- Patent number 8,163,883
- Issue date Apr 24, 2012
- Mission Therapeutics, Inc.
- James Radosevich
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Gene encoding labyrinthin, a marker for cancer
- Patent number 7,635,759
- Issue date Dec 22, 2009
- Immvarx, Inc.
- James A. Radosevich
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Gene encoding labyrinthin, a marker for cancer
- Patent number 7,329,743
- Issue date Feb 12, 2008
- ImmvaRx, Inc.
- James Radosevich
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Gene encoding labyrinthin, a marker for cancer
- Patent number 6,727,080
- Issue date Apr 27, 2004
- ImmvaRx, Inc.
- James Radosevich
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Use of mCRP to enhance immune responses
- Patent number 6,455,046
- Issue date Sep 24, 2002
- Immtech International, Inc.
- Lawrence A. Potempa
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Use of mCRP to slow cell growth and to promote maturation of cells
- Patent number 6,331,403
- Issue date Dec 18, 2001
- Lawrence A. Potempa
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Use of mCRP to enhance immune responses
- Patent number 6,280,743
- Issue date Aug 28, 2001
- Immtech International, Inc.
- Lawrence A. Potempa
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Use of mCRP to enhance immune responses
- Patent number 6,190,670
- Issue date Feb 20, 2001
- Immtech International Inc.
- Lawrence A. Potempa
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Cancer marker protein and peptides thereof
- Patent number 6,166,176
- Issue date Dec 26, 2000
- ImmvaRx, Inc.
- James A. Radosevich
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
GENE ENCODING LABYRINTHIN, A MARKER FOR CANCER
- Publication number 20110110963
- Publication date May 12, 2011
- James Radosevich
- C07 - ORGANIC CHEMISTRY
Information Patent Application
GENE ENCODING LABYRINTHIN, A MARKER FOR CANCER
- Publication number 20100233711
- Publication date Sep 16, 2010
- James Radosevich
- C07 - ORGANIC CHEMISTRY
Information Patent Application
GENE ENCODING LABYRINTHIN, A MARKER FOR CANCER
- Publication number 20100112582
- Publication date May 6, 2010
- James Radosevich
- C07 - ORGANIC CHEMISTRY
Information Patent Application
GENE ENCODING LABYRINTHIN, A MARKER FOR CANCER
- Publication number 20080249284
- Publication date Oct 9, 2008
- IMMVARX, INC.
- James Radosevich
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Gene encoding labyrinthin, a marker for cancer
- Publication number 20050208508
- Publication date Sep 22, 2005
- James Radosevich
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Use of mCRP to enhance immune responses
- Publication number 20030021798
- Publication date Jan 30, 2003
- Immtech International Inc.
- Lawrence A. Potempa
- Y10 - TECHNICAL SUBJECTS COVERED BY FORMER USPC
Information Patent Application
Use of mCRP for delivery of materials into cells
- Publication number 20020061843
- Publication date May 23, 2002
- Lawrence A. Potempa
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
Use of mCRP to slow cell growth and to promote maturation of cells
- Publication number 20020037535
- Publication date Mar 28, 2002
- Immtech International Inc.
- Lawrence A. Potempa
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...

James Radosevich

Person

Patents Grantslast 30 patents

Gene encoding labyrinthin, a marker for cancer

Gene encoding labyrinthin, a marker for cancer

Gene encoding labyrinthin, a marker for cancer

Gene encoding labyrinthin, a marker for cancer

Use of mCRP to enhance immune responses

Use of mCRP to slow cell growth and to promote maturation of cells

Use of mCRP to enhance immune responses

Use of mCRP to enhance immune responses

Cancer marker protein and peptides thereof

Patents Applicationslast 30 patents

GENE ENCODING LABYRINTHIN, A MARKER FOR CANCER

GENE ENCODING LABYRINTHIN, A MARKER FOR CANCER

GENE ENCODING LABYRINTHIN, A MARKER FOR CANCER

GENE ENCODING LABYRINTHIN, A MARKER FOR CANCER

Gene encoding labyrinthin, a marker for cancer

Use of mCRP to enhance immune responses

Use of mCRP for delivery of materials into cells

Use of mCRP to slow cell growth and to promote maturation of cells